percutaneous coronary intervention - search results
If you're not happy with the results, please do another search
Use of Impella CP is feasible in patients with severe aortic stenosis during high-risk percutaneous coronary intervention
Using an Impella device is contraindicated in patients with severe aortic stenosis with a valve ...
Robotically-assisted percutaneous coronary intervention feasible in complex cases
A first-of-its kind study using robotic technology to remotely control coronary guidewires and stents reported on the feasibility of performing percutaneous coronary intervention (PCI) on patients with complex coronary lesions. Similar clinical outcomes compared to the PCI procedure performed manually were reported.
Publication suggests intraaortic balloon pumps as first line choice for high-risk percutaneous coronary intervention patients
Maquet Cardiovascular USA has announced publication of a study comparing the impact of percutaneous ventricular assist devices with intraaortic balloon pumps for high-risk patients undergoing percutaneous coronary intervention.
Abiomed Impella 2.5 receives FDA approval for percutaneous coronary intervention
Impella 2.5 is a ventricular support device used during high risk percutaneous coronary intervention in elective or urgent haemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction.
Bivalirudin use during percutaneous coronary intervention for non-ST segment-elevation acute coronary syndromes is associated with lower bleeding
A study has found that bivalirudin use during percutaneous coronary intervention (PCI) is associated with less composite bleeding when compared with unfractionated heparin monotherapy, in patients with non-ST segment-elevation acute coronary syndromes or stable ischaemic heart disease.
Surprising trends in cause of long-term death after percutaneous coronary intervention
More people who have known coronary heart disease die from other causes - such as cancer, and lung and neurological diseases - than heart disease, compared with 20 years ago, according to a Mayo Clinic study published online in Circulation, an American Heart Association journal.
Do patients who have percutaneous coronary intervention need to stay overnight?
According to a study published in Catheterization and Cardiovascular Interventions, ambulatory percutaneous coronary intervention in patients with stable coronary artery disease is safe and effective
Coronary artery bypass grafting better than percutaneous coronary intervention, five-year comparative registry shows
A large comparative registry undertaken in a "real-world" setting has shown that, at five years, coronary artery bypass grafting demonstrated lower rates of death, myocardial infarction and target vessel revascularisation compared to percutaneous coronary intervention in patients with left main coronary artery or multivessel disease. Results were presented at EACTS.
Women have a higher peri-procedural risk during percutaneous coronary intervention than men but similar long-term outcomes
A large cohort study by Monique Anderson, Durham, USA, and colleagues have found that women experienced higher rates of all-cause in-hospital mortality and were more likely to experience a peri-procedural myocardial infarction, bleeding, and vascular complications than men undergoing percutaneous coronary intervention.
FDA clears robotic-assisted system for percutaneous coronary intervention
Corindus Vascular Robotics has received FDA 510(k) clearance for its CorPath 200 System to be used in percutaneous coronary intervention (PCI) procedures. Results of the PRECISE trial showed that PCI with the system was successfully completed without having to convert to manual percutaneous coronary intervention in 98.8% of patients and without device-related complications.
Robotic-assisted percutaneous coronary intervention is safe and reduces exposure to radiation
Results of PRECISE, a multicentre, pivotal investigation with the CorPath 200 robotic system, were presented at a late-breaking clinical trial at the SCAI annual meeting in Las Vegas.
Statin use associated with a 50% mortality reduction after percutaneous coronary intervention
The results of the study, published in the April 2012 edition of Eurointervention, also showed that patients using atorvastatin had a 23% lower mortality than those using simvastatin.
Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for TAVI
Sachin Goel and Samir Kapadia, Cleveland Clinic, USA, say that PCI can be performed in severe aortic stenosis patients and coronary artery disease without an increase in short-term mortality or procedural complications.
ESC calls for greater awareness of potential for adverse events from bleeding as a result of percutaneous coronary intervention
The European Society of Cardiology (ESC Working Group on Thrombosis) is calling for greater attention to be paid by health care staff to reducing bleeding in patients with acute coronary syndromes undergoing percutaneous coronary interventions, and for increased research in the field.
Ostial left anterior descending arteria stenosis treated by percutaneous coronary intervention and Promus Element everolimus-eluting stent system
Hannu Romppanen and Matti Niemelä discuss the use of the Promus Element everolimus-eluting stent system
Immediate revascularisation non-inferior to staged procedure in acute coronary syndrome and multivessel disease
Immediate, complete revascularisation with percutaneous coronary intervention (PCI) in patients ...
“Urgent” action needed to improve outcomes in women undergoing coronary artery bypass surgery
Women have been found to have significantly higher risk of operative mortality and postoperative...
ADVERTORIAL: DCB therapy offers a glimpse of interventional cardiology’s past and future
This advertorial is sponsored by Cardionovum
“Everything started with balloon inflations in t...
ADVERTORIAL: A wealth of data underscore treatment choices for coronary DCBs
This advertorial is sponsored by B. Braun Melsungen AG
The modern field of percutaneous coron...
The interventional cardiology trials to watch in 2023
Trials in coronary imaging, transcatheter tricuspid valve interventions, transcatheter aortic va...
Medicare study reopens guideline debate around surgery and PCI in patients with multivessel coronary artery disease
An analysis of data from more than 100,000 patients with multivessel coronary artery disease und...
MedAlliance’s Selution SLR receives coronary de novo IDE approval
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional US Food and Dr...
Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures
The use of rivaroxaban for seven days after a transradial coronary procedure reduced the rate of...
ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures
Transradial access for percutaneous coronary procedures is associated with lower rates of all-ca...
ESC 2022: Kidney disease patients with coronary disease see no improvement in survival at five years with an invasive approach
In patients with advanced chronic kidney disease (CKD) and chronic coronary disease, an invasive...
Medtronic launches Onyx Frontier coronary stent following CE mark approval
Medtronic has announced the launch of its latest generation drug-eluting coronary stent—Onyx Frontie...
Stress testing can guide patient selection for coronary revascularisation
Patients identified by nuclear stress testing as having severe stress-induced myocardial ischaem...
FDA approves coronary use of XO Cross support catheter system
Transit Scientific has announced US Food and Drug Administration (FDA) clearance of its XO Cross...
ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ultrasound (IVUS) guide...
Teleflex catheters and coronary guidewires cleared for CTO PCI
Teleflex has announced that the US Food and Drug Administration (FDA) has cleared an expanded indica...
Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant
Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled tri...
First patient enrolled in RISE SC study of coronary balloon
Biosensors has announced the enrolment of the first patient in the RISE SC study, a single arm, pros...
Downgraded guideline recommendations on embolic protection during saphenous vein graft intervention are a step in the right direction
New guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA...
Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases
Cardiovascular Systems recently announced that it has made significant progress towards the commerci...
AATS and STS opt not to endorse joint coronary revascularisation guidelines
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic Surgeons (STS) have...
Heart team approach central to updated coronary revascularisation guidelines
New guidelines for coronary artery revascularisation recommend that treatment decisions should be ba...
Coronary artery modelling technology enables 3D reconstruction of coronary vasculature
RSIP Vision has announced a new coronary artery modelling technology, which enables reconstruction o...
Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB
Cardiovascular Systems has announced the start of enrolment in a first in-human trial of the coronar...
TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet no...
TCT 2021: Philips to showcase developments in its interventional portfolio
Royal Philips has previewed updates in its product portfolio and new data due to be shared at the Tr...
EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials
The underrepresentation of women in clinical coronary revascularisation trials may encourage tre...
Waiting list mortality for coronary procedures exacerbated during pandemic
Patients awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (...
ADVERTORIAL: DCB pioneer welcomes deliverability after first case with Medtronic’s brand new Prevail™ coronary DCB
This advertorial is sponsored by Medtronic
The first case using the Prevail (Medtronic) pacli...
PCI complexity does not influence efficacy of ticagrelor or prasugrel in acute coronary syndrome patients
In patients with acute coronary syndrome treated with percutaneous coronary intervention (PCI), ...
EuroPCR 2021: Interventional cardiologists sound the alarm over silent impact of the pandemic
Interventional cardiologists from across the globe are joining forces for a campaign reinforcing...
AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis
Boston Scientific has announced it has initiated the AGENT IDE trial for the Agent drug-coated ballo...
Pre-existing coronary arterial disease linked to higher rate of myocardial infarction in patients receiving MitraClip
Pre-existing coronary arterial disease (CAD) was associated with higher in‐hospital acute myocardial...
Raising the bar for competency in high-risk coronary procedures
Rhian E Davies (University of Washington Medical Center, Seattle, USA) discusses a recent paper ...
ESC and EACTS to review left main coronary artery stenosis evidence
The European Society of Cardiology (ESC) and the European Association for Cardiothoracic Surgery...
Assessing non-obstructive coronary disease in the cath lab: A tailored approach to treat anginal symptoms
Javier Escaned (Hospital Universitario Clínico San Carlos, Madrid, Spain) discusses the increased in...
Aspirin-free monotherapy after coronary artery stenting is feasible and safe
Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent implantation demons...
Heart teams and interventional cardiologists often differ over recommendations for multivessel CAD
A study comparing recommendations from a heart team versus those of an interventional cardiologi...
Philips introduces Omniwire for coronary artery procedures
Royal Philips has announced the introduction of OmniWire, a solid core pressure wire for coronary ar...
EAPCI issues consensus statement on ischaemia with non-obstructive coronary arteries
The European Association of Percutaneous Cardiovascular Interventions (EAPCI) has published a co...
SCAI release positional statement on optimal PCI for complex coronary artery disease
The Society for Cardiovascular Angiography and Interventions (SCAI) has published a position sta...
Study establishes safety and efficacy of ticagrelor monotherapy in acute coronary syndrome patients treated with Orsiro
According to recently presented TICO trial data, a press release reports, patients with acute co...
COVID-19: Robotics may help to reduce exposure to virus patients during interventional procedures
Studies have shown that robotic percutaneous coronary intervention (PCI) with the CorPath GRX Sy...
Paclitaxel coated balloons have lower risk of mortality in coronary arteries at three years than control treatments
Paclitaxel drug coated balloons (DCB) for percutaneous treatment of coronary artery disease (CAD...
EXCEL may damage relations between interventional cardiologists and cardiac surgeons
The debate over the results of EXCEL shows no sign of abating, and there seems to be a division ...
Patients with angiographically-intermediate coronary lesions
Using optical coherence tomography (OCT)-to guide percutaneous coronary intervention (PCI) is as...
Penumbra announces enrolment of first patient in study of mechanical power aspiration for thrombus removal in coronary vessels
Penumbra has announced the enrolment of the first patient into the CHEETAH study, a prospective,...
ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI and multivessel CAD irrespective of timing of intervention
A strategy of complete revascularisation was superior to culprit lesion-only percutaneous corona...
ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary syndromes
Stefanie Schüpke (Deutsches Herzzentrum München, and Technische Universität München, Munich, Ger...
EuroPCR 2019: Consensus paper on intracoronary imaging focuses on acute coronary syndrome
A consensus paper on the use of intracoronary imaging was released at EuroPCR 2019 (20–24 May, P...
Cordis expands its interventional cardiology portfolio with full US launch of radial products
Cordis, a Cardinal Health company, has announced the full US launch of its Radial 360 portfolio, off...
Less than half of vein graft interventions use embolic protection
Current US guidelines recommend the use of embolic protection during saphenous vein graft percut...
First patient in Hong Kong receive treatment with coronary Orbital Atherectomy System
The first patient in Hong Kong has been treated with the Diamondback 360 coronary Orbital Athere...
ESC 2018: Non-atherosclerotic spontaneous coronary artery dissection predominantly affects young to middle-aged women
Data from the Canadian Spontaneous Coronary Artery Disease (CanSCAD) study indicate that the maj...
Physicians are more willing to tolerate uncertainty about coronary artery disease testing if risk of malpractice is less
Steven Farmer (Center for Healthcare Innovation and Policy Research, George Washington Universit...
Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses
Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver ...
ACC 2018: Short-term DAPT after PCI in acute coronary syndrome patients is not safe
Data from the SMART-DATE study indicate that acute coronary syndrome patients who receive short-...
Corindus Vascular Robotic to co-sponsor courses on transradial coronary interventions
Corindus Vascular Robotics will be co-sponsoring courses at multiple leading hospitals to educat...
Recommendations for the use of embolic protection devices during saphenous vein graft intervention may need revising
A meta-analysis—published in Circulation Cardiovascular Interventions—indicates that the routine...
Interventional cardiology in the Twitterverse
The past few years has witnessed increasing clinician engagement with social media platforms, in...
Coronary angiography after TAVI with a self-expanding valve is challenging but feasible
A new study indicates that coronary angiography, with or without percutaneous coronary intervent...
ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome
During a late-breaking science session at the European Society of Cardiology (ESC) congress (26–...
EuroPCR 2017: Safety of deferring stenting in acute coronary syndrome patients is OK but could improve
A pooled patient-level analysis of patients undergoing physiological assessment, with either fra...
Survival benefit of early intervention in non-STEMI patients is independent of other factors
Sameer Arora (Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, ...
OrbusNeich announces FDA clearance and launch of coronary dilatation catheters
OrbusNeich has announced the launch of its Sapphire percutaneous coronary angiography balloon dilata...
High HbA1c levels after coronary intervention may predict risk of adverse events
A new study indicates that patients with glycosylated haemoglobin A (HbA1c) ≥7 at two years after un...
Cardiovascular Systems enrols first subject in ECLIPSE coronary clinical trial
Cardiovascular Systems and the Cardiovascular Research Foundation (CRF) have announced that the ...
ACC 2017: “iFR may be the new standard” of physiological assessment of coronary lesions
Writing in The New England Journal of Medicine, Deepak L Bhatt (Brigham and Women’s Hospital and...
American College of Cardiology update appropriate use criteria for performing coronary revascularisation in patients with stable disease
The American College of Cardiology (ACC), along with several partnering organisations, has relea...
RenalGuard significantly reduces risk of contrast-induced acute kidney injury in high-risk patients undergoing interventional procedures
A new meta-analysis, published in JACC: Cardiovascular Interventions, indicates that RenalGuard ...
Homemade pelvic drape significantly reduces radiation exposure to the operator during transradial coronary interventions
The RADIATION (Radiation dose in percutaneous coronary procedures through transradial approach u...
Perform PCI prior to TAVI in patients with both coronary artery disease and aortic stenosis
Stephen Ramee (Ochsner Medical Center, New Orleans, USA) and others outline in a paper in JACC: ...
TCT 2016: Cardiovascular System initiates largest ever randomised trial of coronary atherectomy for calcified lesions
At the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Wash...
TCT 2016: Breakfast symposium to explore robotic therapy in interventional cardiology
Corindus Vascular Robotics is to host a breakfast symposium entitled “Robotic Therapy—current Ap...
Young women with premature acute coronary syndrome now do as well as men
It has become commonly accepted that women do worse than men following a heart attack or other coron...
Frequency of coronary perforation “might actually increase” given predictors include old age
Tim Kinnaird (Department of Cardiology, University Hospital of Wales, Cardiff, UK) and others re...
Study confirms safety of using Tryton stent to treat coronary bifurcation lesions involving large side branches
The Tryton Confirmatory Study, recently published in JACC Cardiovascular Interventions, has confirmed the safety and efficacy of the Tryton Side Branch Stent for the treatment of coronary bifurcation lesions involving large side branches (appropriate for a ≥2.5mm stent).
Trials on newer generation drug-eluting stents in small coronary vessels needed
A network meta-analysis of early generation, drug-eluting stents, bare metal stents, drug-coated balloons, and balloon angioplasty indicate that sirolimus-eluting stents are associated with the most favourable angiographic and clinical outcomes for lesions in small coronary arteries.
The risk of acute kidney injury during complex cardiac interventions: Rationale of the STRENGTH study
Although most patients undergoing complex cardiac or vascular interventions tolerate contrast, some will develop contrast-induced acute kidney injury-which is associated with increased mortality. In this commentary, Philippe Garot and Andrew Roy review the aims and objectives of the ongoing STRENGTH trial.
Polymer-free coronary stent more effective and safer than bare metal stent in ACS patients
Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous coronary intervention (PCI) with a polymer-free biolimus-A (BA9) drug-coated stent than with those receiving a bare metal stent in results from a sub-study of the LEADERS FREE trial reported for the first time in a late-breaker session at EuroPCR 2016.
Young female acute coronary syndrome patients have significantly greater comorbidities than their male counterparts
A study indicates that women aged less than 55 years with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) have significantly greater comorbidities and worse outcomes than their male counterparts.
PCI does not reduce readmission rates for patients with syncope and obstructive coronary artery disease
Lindsay Anderson and others report that, compared with medical management, PCI is not associated with a significant reduction hospital readmission for syncope in older patients with syncope and obstructive coronary artery disease.
Complete PCI in STEMI: An interventional paradigm shift
In a new focused update, the ACC/AHA/SCAI now recommend that complete PCI is acceptable in some patients with STEMI with multivessel disease. Eliano P Navarese reviews the evidence base for complete PCI compared with culprit-artery only PCI.
Expert consensus statement for treatment of cardio-oncology patients released by the Society for Cardiovascular Angiography and Interventions
The statement is intended to provide cardiologists, oncologists and internal medicine physicians with guidance for treating patients facing both cardiovascular disease and cancer.
Retrograde coronary revascularisation in Europe to treat chronic total coronary occlusions
Alfredo R Galassi reports on the use of PCI with the retrograde approach for the management of CTOs in Europe and how the Euro CTO Club and Live Summit are spreading the knowledge of new complex PCI techniques for CTOs.
CE mark for Svelte Medical’s sirolimus-eluting coronary stent-on-a-wire integrated delivery system
Svelte Medical Systems has received the CE mark for its Slender sirolimus-eluting coronary stent-on-a-wire integrated delivery system for the treatment of coronary artery disease.
Mind the gender gap: Addressing inequalities in interventional cardiology
With only 4.5% of US interventional cardiologists being female, Cardiovascular News reviews the steps being taken to ensure that being female is not a barrier to being an interventional cardiologist.
An interventional cardiologist’s view on left atrial appendage closure
Martin W Bergmann is an interventional cardiologist working in Germany, who performs percutaneous LAA closure procedures. He explores why there is still a need for such procedures even in the era of novel oral anticoagulants.
CeloNova announces FDA approval to start a Cobra PzF coronary stent system randomised trial
This is a second major interventional cardiology trial for CeloNova in the USA, following the successful enrolment of the PzF SHIELD clinical trial earlier this year.
Rediscovering the transfemoral approach for structural heart interventions
Before we abandon "the good old femoral route" completely, the advent of structural heart disease interventions means that we still have a use for the approach. Flavio Ribichini explores the use of the transfemoral approach with these interventions.
Clinical trial launched to test if coronary stent patients can avoid taking aspirin
The international clinical trial TWILIGHT will test the safety and effectiveness of treating coronary stent patients with the anti-clotting medication ticagrelor instead of combining it with aspirin.
Men believe “long working hours” stop women from being interventional cardiologists
According to a new survey published in EuroIntervention, men state that the long working hours and the need to be on call that is associated with being an interventional cardiologist are the key reasons why so few women choose the subspecialty.
Comparable outcomes between PCI and surgery in diabetic patients with acute coronary syndromes and multivessel disease
The ACUITY study indicates that there are no significant differences in rates of myocardial infarction or death between diabetic patients with acute coronary syndromes and multivessel disease undergoing PCI and those undergoing CABG.
Availability of HeartFlow FFRCT Analysis may change the management of patients with coronary artery disease
Results of the FFRCT RIPCORD study were presented at EuroPCR 2015 (19-22 May, Paris, France) by Nick Curzen of the University Hospital Southampton, UK.
ICI meeting is a “fruitful ground for new developments” in interventional cardiology
Rafael Bayer, co-chairman of the Innovation in Cardiovascular Intervention (ICI) meeting (14–16 December 2014, Tel Aviv, Israel), speaks to Cardiovascular News about the event's unique features.
Low rate of target vessel revascularisation with Cobra PzF coronary stent
CeloNova BioSciences has announced that positive first-in-man clinical trial results indicate that its Cobra PzF coronary stent system, which has a nano-thin coating of polyzene-F polymer, is a safe and effective routine treatment for real-world and complex patients with heart disease.
CE mark approval for Enabler-C coronary catheter system
The CE mark of the Enabler-C coronary catheter system follows the successful first-in-man study of the Enabler-C that took place at the Institut Cardiovasculaire Paris-Sud.
Drug-coated balloons for the management of coronary artery disease
Robert Byrne writes that although drug-coated balloon therapy has been a significant innovation with relevance for everyday practice, convincing data in the coronary arena exists thus far only for the treatment of in-stent restenosis.
Pre-hospital ticagrelor does not improve coronary reperfusion before PCI in STEMI patients
Pre-hospital administration of ticagrelor does not improve coronary reperfusion before percutaneous coronary intervention patients with ST-segment elevation myocardial infarction. However, it may reduce the risk of stent thrombosis.
A simple intervention could prevent acute kidney injury in one in five PCI patients
According to a new study, a simple cost-effective multicentre quality improvement intervention could prevent contrast-induced acute kidney injury in one in five patients undergoing non-emergent percutaneous coronary intervention.
“Interventional cardiology is losing more than 50% of the talent pool”
The Women Committee of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) has been set up to attain gender equality in interventional cardiology at the professional and patient level. The chair of the committee, Julinda Mehilli speaks to Cardiovascular News about why the comparative lack of women in interventional cardiology means that the specialty is "losing more than 50% of the talent pool".
Coronary revascularisation in diabetic patients: Where do we stand?
Ehrin Armstrong reviews the revascularisation options and medical therapy for patients with diabetes and coronary artery disease.
Majority of patients believe PCI cures their coronary artery disease
A survey has found that barely one in four patients who have undergone percutaneous coronary intervention know that they still have coronary artery disease as many patients believe that the procedure cures their condition.
The transformation of the coronary stent
Adrian Banning charts the evolution of the stent from the original bare metal design to bioabsorbable scaffold and biodegradable polymers. He also looks at the challenges of further improving stent design
PCI and bypass graft surgery: Which intervention and in whom?
Marie-Claude Morice discusses data for CABG vs. data for PCI and how newer generation drug-eluting stents may affect the future treatment of patients with coronary artery disease.
Cardiovascular Systems receives coronary FDA approval
Cardiovascular Systems announced that it has received approval from the US Food and Drug Administration (FDA) to market its Diamondback 360 Coronary Orbital Atherectomy System (OAS) as a treatment for severely calcified coronary arteries.
“Significant capability” reported for Enabler-C Catheter System for crossing coronary chronic total occlusions
Thirty per cent of percutaneous coronary intervention (PCI) procedures aimed at the recanalisation of chronic total occlusion fail, with the major cause being the inability of the guidewire to cross the target lesion. The Enabler-C Catheter system is designed to offer a new solution for the treatment of these challenging lesions, according to Endocross.
Incidence of rare coronary obstruction carries high acute and late mortality rates but is preventable
According to the results of a large multicentre registry, patients who undergo TAVI can suffer a rare and life-threatening complication coronary obstruction. The registry investigated the main baseline, procedural characteristics and management of clinical outcomes in patients who experienced coronary obstruction.
Self-apposing stent approved for additional coronary interventions
Stentys has announced that it has received approval to expand the CE mark indications of its self-apposing coronary stent.
Mitral valve repair in severe mitral regurgitation: An interventional cardiologist’s perspective
Sachin Goel and Samir Kapadia review the different interventional methods of managing mitral regurgitation
Transulnar approach should not be used as default strategy for coronary procedures
A study has found that the transulnar approach for coronary procedures is associated with significantly higher crossover rates compared with the transradial approach.
Late-breaking ORBIT II coronary data to be presented at EuroPCR
The ORBIT II trial evaluating safety and effectiveness of the orbital atherectomy system in treating calcified coronary lesions is expected to presented as late-breaking data at EuroPCR (21–24 May, Paris, France).
Delayed coronary artery healing after implantation of drug-eluting stents is a concern
According to an online survey of 141 interventional cardiologists worldwide, the use of drug-eluting stents and the delay to healing is a concern.
REMEDEE study published in JACC: Cardiovascular Interventions
The REMEDEE study, which showed that OrbusNeich's Combo dual therapy stent is effective at controlling neo-intimal proliferation, has been published in the journal JACC: Cardiovascular Interventions.
The evolution of percutaneous valve technology
Following on from the use of percutaneous technology in peripheral vascular disease and in coronary artery disease, percutaneous technology is now being used to treat valvular dysfunction. Jose L Navia and Sharif Al-Ruzzeh review its application in this context
Predictors of cardiac death in patients with coronary chronic total occlusion not revascularised by PCI
Cosmo Godino, Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy, writes that not all efforts should be directed toward technical and procedural aspects to achieve final chronic total occlusion-PCI recanalisation.
New PLATO sub-analysis demonstrates efficacy of ticagrelor compared to clopidogrel in acute coronary syndrome patients
Results showed that ticagrelor plus aspirin, compared to clopidogrel plus aspirin, reduced cardiovascular death, myocardial infraction and stroke in acute coronary syndrome patients regardless of coronary artery disease extent and treatment strategy.
CathPCI registry shows contemporary state of interventional cardiology practice in USA
The report published online in The Journal of the American College of Cardiology (JACC) analyses data from 1.1 million patients who underwent diagnostic cardiac catheterisation procedures and 941,248 patients treated with percutaneous coronary intervention from January 2010 to June 2011.
Coronary artery stenting combined with minimally invasive valve surgery may be an alternative to CABG and valve surgery
A study lead by researchers from the Mount Sinai Medical Center in Miami, USA, has found that patients with coronary valvular disease who were treated with a hybrid approach combining coronary artery stenting with minimally invasive valve surgery showed significantly better outcomes than patients who had standard sternotomy coronary bypass and valve surgery.
PROTECT study confirms long-term safety of drug-eluting coronary stents
Largest prospective randomised drug-eluting stent trial ever presented, ESC late-breaker on the PROTECT study reveals low rates of stent thrombosis through three years of follow-up.
New ESC guidelines recommend ticagrelor in acute coronary syndromes patients with ST-elevation
Ticagrelor received a class I recommendation from the ESC in the revised Guidelines on the Management of Acute Myocardial Infarction in Patients Presenting with STEMI.
Philips and Corindus announce distribution agreement to sell Corindus’ robotic-assisted interventional cardiology system in the USA
Philips becomes the exclusive distributor of Corindus' CorPath 200 System, the world's first robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries.
Radiation exposure during coronary angiography via transradial or transfemoral approaches: Does operator experience matter?
Binita Shah, New York University School of Medicine, New York, USA, explains the results of a study that demonstrated that even in the hands of experienced operators, radiation exposure is higher when using transradial approach compared with transfemoral approach.
Depression increases death risk in coronary stent patients
After seven years of follow-up, depressed patients were 1.5 times more likely to have died than non-depressed patients, research presented at 12th Annual Spring Meeting on Cardiovascular Nursing has shown.
Fluoroscopy times and radiation exposure during renal denervation compared to coronary procedures
A retrospective analysis conducted in Germany shows that fluoroscopy times and radiation exposure in patients undergoing renal denervation are similar to those in patients undergoing routine diagnostic catheterisation with elective percutaneous coronary intervention but lower than in patients undergoing emergency intervention.
Miracor receives Austrian funding to begin RAMSES clinical trial of its Picso system for acute coronary syndrome patients
The RAMSES trial is designed to understand how Picso can help acute coronary syndrome patients with large anterior infarcts having ECG changes with poor microcirculation after revascularisation.
Genous stent demonstrates most rapid coronary vessel healing compared to bare metal and drug-eluting stents at 14 days post-implantation
The Genous stent (OrbusNeich) had 69.7% healed and 5.3% malapposed struts compared to 56.7% healed and 19.7% malapposed struts for the Blazer stent (OrbusNeich), 55.2% healed and 13.9% malapposed struts for the SolarFlex stent (Disa Vascular) and 34% healed and 45.7% malapposed struts for the Nobori stent (Terumo).
Pioneer of interventional cardiology in China receives Ethica Award 2011
Run-Lin Gao, described as "the father of interventional cardiology in China" spoke to Cardiovascular News about the Ethica Award recognition, the development of interventional cardiology in China, and the 10th China Interventional Therapeutics (CIT) conference, taking place in Beijing in March 2012.
Coronary artery stenting viable palliative option for infants and toddlers
A study led by András Bratincsák from Rady Children's Hospital in San Diego, USA, conducted a review of seven children who underwent intervention between June 2006 and June 2010.
InfraReDx initiates CANARY clinical trial of LipiScan IVUS coronary imaging guidance
CANARY is designed to test the hypothesis that near-infrared guided use of an embolic protection device, during percutaneous coronary intervention can reduce the rate of peri-procedural heart attacks in patients identified as having high-risk lipid core plaques.
PCI shows promising results in patients with infarction and thrombosis of the unprotected left main coronary artery
At one-year follow-up, in-hospital survivors had a mortality rate of 10.5%, whereas 18.4% experienced subsequent major adverse cardiac events.
Positive results for unprotected left main coronary artery PCI with drug-eluting stents
Intervention is Viable Option for Low-Risk Patients with Normal Function in Left Ventricle, according to a paper published in Catheterization and Cardiovascular Interventions.
GATEWAY Registry: Addressing bleeding risk in patients with acute coronary syndrome
David Smith, principal investigator of the GATEWAY Registry trial, spoke to Cardiovascular News on treatment for acute coronary syndrome patients, their bleeding risk complications from receiving antiplatelet therapy and the GATEWAY Registry that seeks to address this risk.
First ESC/EACTS guidelines on coronary revascularisation
Eduardo AlegrÃa Barrero, Cardiology and Cardiovascular Surgery, Rotger Clinic, Palma de Mallorca, Spain, and Eduardo AlegrÃa Ezquerra, Cardiology and Cardiovascular Surgery, Guipuzcoa Policlinic, San Sebastian, Spain, explained the first ESC/EACTS guidelines on myocardial revascularisation.
SCAI publishes statement on standards for quality assessment and improvement in interventional cardiology
This is the first document offering guidance regarding core measures for quality and assessment in percutaneous coronary intervention programmes.
Registry will investigate the Genous stent in patients with acute coronary syndrome and high-risk of post-procedural bleeding
GATEWAY registry will assess the performance of the device in providing anti-ischaemic protection while providing bleeding safety by the use of shortened dual antiplatelet therapy.
FDA gives conditional approval for pivotal study to evaluate robotic-assisted placement of coronary guidewires and stent/balloon catheters
The clinical endpoint of the trial is the ability to treat the patient without the incidence of major adverse cardiovascular events, also to monitor the radiation exposure of interventional cardiologist while using the CorPath (Corindus) technology.
Sheathless transradial intervention highly successful in treating complex lesions
Novel approach to angioplasty uses standard guiding catheters; promotes widespread adoption of transradial approach in the USA.
Transcatheter mitral interventions: MitraClip and beyond
"We will witness the introduction of new devices to enrich the treatment portfolio, the development of image guidance to plan and execute the procedures, and the evolution of new clinical trends and, potentially, updated guidelines," Franscesco Maisano, Milan, Italy, writes to Cardiovascular News.
NICE recommends prasugrel plus aspirin for acute coronary syndromes
New guidance recommending the use of prasugrel in combination with aspirin as an option for preventing blood clots in the arteries of people with acute coronary syndromes has been published by the National Institute for Health and Clinical Excellence (NICE).
(Drug-eluting?) Coronary stenting in patients on chronic oral anticoagulation
Andre Rubboli, Bologna, Italy, analyses a polymer-free, Carbofilm coated stent eluting tacrolimus from abluminal reservoirs, which has been widely tested in patients with either stable or unstable coronary artery disease.
Taxus and Cypher safe for unprotected left main coronary artery disease
According to study published in the Journal of the American College of Cardiology, both stents provide comparable clinical and angiographic outcomes.
Robotic-assisted PCI is safe and feasible for complex procedures
Results from the CORA-PCI (Complex robotically assisted percutaneous coronary intervention) indicate that robotic-assisted percutaneous coronary intervention (PCI), using the CorPath system (Corindus Vascular Robotics), is a safe and feasible approach to managing patients with complex lesions.
Device reduces volume of radiographic dye in patients at risk of developing acute kidney injury
In the largest study of its kind, the Avert device from Osprey Medical has been found to significantly reduce the volume of radiographic dye without decreasing image quality in patients who are at risk of developing acute kidney injury after undergoing a coronary angiography or percutaneous coronary intervention.
Impella can now be used in USA for cardiogenic shock after myocardial infarction
Abiomed has received FDA pre-market approval for its Impella 2.5, Impella CP, Impella 5.0 and Impella LD heart pumps for the treatment of ongoing cardiogenic shock. This latest approval adds to the prior FDA indication of Impella 2.5 for high risk percutaneous coronary intervention (PCI), or Protected PCI.
The Medicines Company to present antithrombotic agent data at 2016 ACC meeting
Investigators will present new analyses from high-risk percutaneous coronary intervention (PCI) patient subgroups from the CHAMPION PHOENIX study with The Medicine Company's antithrombotic agent, Kengreal (cangrelor) for injection.
Thrombus aspiration does not improve 12-month outcomes according to TATORT-NSTEMI trial
TATORT-NSTEMI is the first randomised trial investigating the impact of thrombectomy before percutaneous coronary intervention.
PiCSO highlighted at TCT as novel therapy
Miracor Medical Systems have reported that, during this year's TCT meeting, PiCSO has been highlighted in several sessions as offering new hope for cardioprotection during percutaneous coronary intervention.
Corindus Vascular Robotics and Mayo Clinic Launch Vascular Robotic Program to Research Physician Safety
Corindus Vascular Robotics has announced the formation of a joint robotic-assisted percutaneous coronary intervention (PCI) research and clinical program. This program utilises Corindus' CorPath System whilst protecting hospital employees from occupational radiation exposure and orthopedic stress and strain.
Robotic PCI can now be used for radial access procedures in USA
The FDA has given 510(k) clearance to Corindus Vascular Robotics for its robotic-assisted CorPath System to be used during percutaneous coronary intervention (PCI) performed via radial access. The 510(k) clearance was based on results of a clinical trial, with an enrolment of 30 patients, that demonstrated 100% device and clinical success.
Thoratec announces start of SHIELD II US clinical trial
The SHIELD II US clinical trial will examine the use of the HeartMate PHP in patients undergoing a high-risk percutaneous coronary intervention (PCI) procedure.
First participants enrolled in dabigatran study of AF patients undergoing PCI
Boehringer Ingelheim has announced that the first US patients have been enrolled in its international clinical trial-RE-DUAL PCI, which is evaluating the efficacy and safety of dabigatran in patients with non-valvular atrial fibrillation who have undergone percutaneous coronary intervention (PCI).
New data add to evidence base for FFR
New results from two clinical studies, both of which were presented at EuroPCR (19-22 May, Paris, France) provide further support to the use of St Jude Medical's fractional flow reserve (FFR) technology to optimise percutaneous coronary intervention (PCI) procedures.
New trial does not support earlier findings that complete revascularisation improves outcomes
Results from the PRAGUE 13 trial indicate that there are no significant differences in outcomes between staged percutaneous coronary intervention (PCI) and culprit-only PCI in patients with multivessel disease; these results differ from those of earlier studies.
Thoratec receives conditional FDA approval for the SHILED II US clinical trial for HeartMate PHP
The clinical trial will examine the use of Thoratec's HeartMate PHP acute catheter-based heart pump in patients undergoing a high-risk percutaneous coronary intervention.
EuroPCR 2015 Orsiro hybrid drug-eluting stent data highlights safety and efficacy in high-risk patients
Experts at the Biotronik-sponsored symposium discussed Orsiro's performance in difficult cases as well as coming developments in percutaneous coronary intervention.
PICSO system has potential to improve myocardial recovery after PCI
The first safety and feasibility study of pressure-controlled intermittent coronary sinus occlusion (PICSO) in the setting of ST-segment elevation myocardial infarction indicates that the system could potentially enhance myocardial recovery after primary percutaneous coronary intervention.
Prognosis is significantly worse with non-access site bleeding
A meta-analysis of site-specific bleeding after percutaneous coronary intervention indicates that non-access site bleeding is associated with a significantly worse prognosis than is access-site bleeding.
Robotic PCI could be used to reduce radiation exposure to the operator
Ryan Madder, an interventional cardiologist at the Frederik Meijer Heart & Vascular Institute (Spectrum Health, Grand Rapids, Michigan, USA) explains why he believes a robotic system (CorPath, Corindus Vascular Robotics) for performing percutaneous coronary intervention (PCI) may help to reduce radiation exposure.
Surgery is still BEST for multivessel disease in the long run
The results of the BEST study indicate that, in patients with multivessel disease, coronary artery bypass grafting (CABG) is associated with significant better outcomes than percutaneous coronary intervention (PCI) even in the era of second-generation drug-eluting stents. However, a registry study has indicated that there is no difference in mortality rates between PCI with everolimus-eluting stents and CABG
Meta-analysis indicates that bivalirudin does increase risk of early stent thrombosis
A new meta-analysis shows that bivalirudin significantly increases the risk of early stent thrombosis in patients undergoing percutaneous coronary intervention compared with other antithrombotic therapies. However, this increase in stent thrombosis is not associated with an increased risk of death or myocardial infarction.
Physician safety and stent savings with robotic-assisted PCI to be presented at CRT 2015
Paul T Campbell has explored the stent savings made possible when robotic percutaneous coronary intervention (PCI) is leveraged for the measurement of anatomy in place of manual methods of measurement.
The data for thrombectomy are conflicting
Sanjit Jolly writes that data suggest that impaired microvascular perfusion after primary percutaneous coronary intervention (PCI) is strongly associated with subsequent mortality.1 Manual thrombectomy aims to reduce distal embolisation and improve microvascular perfusion during primary PCI.
First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting
The study will evaluate the efficacy and safety of the oral anticoagulant dabigatran etexilate in patients with non-valvular atrial fibrillation, who have undergone a percutaneous coronary intervention (PCI) with stent placement to widen their blocked coronary arteries.
The role of rotational atherectomy in contemporary PCI practice
James Cockburn, David Hildick-Smith, and Adam de Belder describe their recent study (published in the International Journal of Cardiology), which found that patients who underwent rotational atherectomy had a lower mid-term survival compared with patients who underwent conventional percutaneous coronary intervention (PCI).
Transradial access predicts survival in NSTEMI patients
A new study suggests that transradial access in patients with non-ST-segment elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention is associated with reduced bleeding and reduced mortality compared with transfemoral access.
Novel anticoagulation system for PCI patients is effective at supressing ischaemic events without compromising bleeding
A novel anticoagulation system, comprising of a single-stranded RNA factor IXa inhibitor (pegnivacogin) and its reversal agent (anivamersen), was shown to be safe and feasible for supressing both ischaemic events and thrombotic complications with a favourable bleeding profile in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Manual thrombus aspiration associated with a higher rate of direct stenting
Data from the EXAMINATION trial indicates that manual thrombus aspiration prior to primary percutaneous coronary intervention (PCI) is associated with a higher rate of direct stenting and a lower rate of postdilation than no manual thrombus aspiration prior to primary PCI.
Positive results for iMOS Prime registry for the MGuard Prime embolic protection system
InspireMD has announced new results from the iMOS (International MGuard Observational Study) Prime registry demonstrating that use of the MGuard Prime in cases of acute ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention resulted in complete ST-resolution in approximately 75% of cases, and a 2.2% rate of major adverse cardiac events at 30 days, including zero cases of mortality.
Peri-PCI bleeding in patients with diabetes carries “significant” increased risk of mortality
A study among patients with diabetes, drawn from seven randomised trials, has shown that bleeding within 30 days of percutaneous coronary intervention is associated with an increased risk of one-year mortality, non-fatal myocardial infarction or stent thrombosis.
Analysis of EUROMAX and HORIZONS-AMI trials of Angiomax (bivalirudin) presented at ACC
New pooled analysis of 5,800 patients shows bivalirudin is associated with reductions in cardiac death, major bleeding, transfusion and net adverse clinical events in STEMI patients undergoing percutaneous coronary intervention.
New partnership to launch remote robotics programme
The remote robotics programme envisions enabling remote robotic-assisted percutaneous coronary intervention for patients in rural areas. The remote robotics programme is the product of a partnership between Corindus Vascular Robotics and Sandford Health and the Leona M and Harry B Helmsley Charitable Trust.
Fasting may not be necessary for PCI patients
The traditional practice of keeping patients nil-by-mouth for four-to-six hours prior to an elective percutaneous coronary intervention (PCI) procedure may not always be necessary as a retrospective study has found that not fasting before PCI is safe.
The use of vascular robotic systems for PCI
Ronald P Caputo writes about robotic systems for percutaneous coronary intervention designed to provide greater accuracy of lesion measurement, aid in better advancement of guidewires and help ensure correct placement of stents.
FDA reviewer says no to cangrelor for PCI
In a clinical review evaluating cangrelor for reducing thrombotic cardiovascular events during percutaneous coronary intervention, one reviewer says the drug should not be recommended for this indication because studies have failed show that a cangrelor regimen is superior or non-inferior to a clopidogrel regimen or standard of care.
Recurrent chest discomfort is the most common cause of readmission after PCI
A study published ahead of print in Circulation: Cardiovascular Interventions shows that the most common cause of readmission after percutaneous coronary intervention is recurrent chest discomfort. However, few patients with recurrent chest discomfort meet the criteria for myocardial infarction.
Meta-analysis raises questions about ischaemia-driven revascularisation
A meta-analysis indicates that percutaneous coronary intervention does not reduce the risk of death, non-fatal myocardial infarction, unplanned revascularisation, or angina compared with medical management alone in patients with stable coronary artery disease and myocardial ischaemia.
Conservative revascularisation is non-inferior to aggressive revascularisation
The one-year results from the SMART-CASE study indicate that a conservative strategy of only performing percutaneous coronary intervention if the diameter stenosis of the target lesion is >70% is non-inferior to an aggressive strategy of performing PCI if the diameter stenosis is >50%.
New study will test personalised antiplatelet therapy
Roche has started a new study TROPICAL-ACS that will evaluate the benefit of personalised antiplatelet therapy in patients who have acute coronary syndrome treated with percutaneous coronary intervention.
Six to 12 months is the right timeframe for dual antiplatelet therapy
During the Great Debate at this year's EuroPCR (21–24 May, Paris, France), leading experts in interventional cardiology discussed the use of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). The key issues raised were the optimum duration of DAPT with second-generation, drug-eluting stents and the use of new, more potent, antiplatelets.
New range of PCI guidewires launched
Biotronik has launched the Galeo Pro, which is a new range of percutaneous coronary intervention (PCI) guidewires
Cardiogenic shock is strongest predictor of stent thrombosis
According to an all-comers registry published in EuroIntervention and presented at EuroPCR (21–24 May, Paris, France), cardiogenic shock is the strongest predictor of stent thrombosis following percutaneous coronary intervention.
New imaging technique could improve stenting of bifurcations lesions
StentBoost, a new imaging technique that enhances stent fluoroscopic visibility, is a simple and quick method that offers several advantages during percutaneous coronary intervention in patients with bifurcation lesions
Superiority of bivalirudin over heparin questioned
Results from a large observational study, presented at EuroPCR (21–24 May, Paris, France) suggest that in the absence of GP IIb/IIIa receptor inhibitors, bivalirudin does not improve outcome compared with heparin in patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
Transradial access will probably become the default primary PCI strategy
Daniel Steinberg reviews the transradial approach in primary percutaneous coronary intervention (PCI) and looks at why the USA has been reluctant to adopt the approach despite it reducing access site and bleeding complications compared with the transfemoral approach
New risk score could predict risk of bleeding after PCI
A new risk score, developed using data from the RISK-PCI study, could be used to identify which patients are at high risk of bleeding after undergoing a percutaneous coronary intervention (PCI) procedure.
Black and Hispanic patients have worst outcomes after PCI
A study published in Circulation indicates that compared with white patients, black and Hispanic patients have worse outcomes following percutaneous coronary intervention (PCI).
Cangrelor significantly reduces ischaemic events compared with clopidogrel
New study, CHAMPION PHOENIX, indicates that cangrelor significantly reduces the rate of ischaemic events including stent thrombosis compared with clopidogrel in patients undergoing urgent or elective percutaneous coronary intervention.
Microvascular resistance increases after angioplasty in NSTEMI patients
A new study indicates that microvascular resistance, contrary to previous studies, increases after percutaneous coronary intervention and this increase is not linked to increasing epicardial stenosis.
The National Cardiovascular Data Registry is a “national treasure”
For the first time, the National Cardiovascular Data Registry (NCDR) has published in the Journal of the American College of Cardiology a general report of data from the CathPCI registry, which characterises the clinical profile and outcomes of patients undergoing cardiac catheterisation and percutaneous coronary intervention procedures. Lead author of the report, Gregory Dehmer, reviews the report's key findings.
FFR-guided PCI is “economically attractive”
Reporting on the results of an economic analysis of the FAME II study, at TCT, William Fearon, Stanford, USA, said that fractional flow reserve (FFR) guided percutaneous coronary intervention (PCI) was cost-effective, compared with medical management, in patients with stable coronary disease (CAD).
Bypass surgery better than angioplasty in diabetic patients
A comparative study has shown, at five years, that diabetic patients who underwent bilateral internal thoracic artery grafting had a 13% greater survival rate, as well as a lower risk for non-fatal heart attacks, recurrent chest pain, and future re-interventions, compared to patients treated with percutaneous coronary intervention.
New retrospective studies of prasugrel vs. clopidogrel presented at TCT
The studies evaluated hospital readmission rates for subsequent heart attack and initial hospitalisation costs in patients with acute coronary syndrome treated with a percutaneous coronary intervention and antiplatelet therapy, including prasugrel or clopidogrel.
Siemens delivers advanced cardiovascular CT training with the British Institute of Radiology
The four day training course offered hands-on training, analysis of cardiac CT data sets including post-percutaneous coronary intervention and surgery assessment skills.
NEJM publishes FAME II trial results revealing better patient outcomes with FFR-guided cardiac stenting
Instances of hospital re-admission leading to urgent revascularisation were reduced by 86% for patients in the FFR-guided percutaneous coronary intervention arm of the trial.
PRECISE study shows robotically enhanced PCI is safe and feasible
Results of the multicentre PRECISE study show effectiveness of a robotic-assisted system for patients and enhanced safety for interventional cardiologists performing percutaneous coronary interventions.
St Jude Medical announces next-generation PressureWire for FFR measurement
The PressureWire with Agile Tip was designed to replicate the performance of standard percutaneous coronary intervention guidewires and deliver exceptional handling even in the most challenging anatomies.
Drug-eluting balloons are a promising tool in treatment of in-stent restenosis
Percutaneous coronary intervention with a drug-eluting balloon for in-stent restenosis is a promising effective therapeutic option with an unexpected low repeat restenosis and target lesion revascularisation rate, according to research presented at the American Heart Association's Scientific Sessions 2011.
Genous stent demonstrates long-term safety and efficacy in large patient population
OrbusNeich announced that three-year clinical outcomes data from the use of the Genous stent for percutaneous coronary interventions in a large, real-world patient population demonstrate the device's long-term safety and efficacy.
Do drug-eluting stents increase the rate of late stent thrombosis compared to bare metal stents in STEMI patients? The DESERT cooperation
Giuseppe De Luca, Novara, Italy, comments on the results of the DESSERT (Drug-eluting stents in primary angioplasty) cooperation, a meta-analysis of randomised trials which aimed to evaluate the risks and benefits of drug-eluting stents in comparison to bare metal stents in patients undergoing primary percutaneous coronary intervention for STEMI.
Increased risk of death is not associated with same-day discharge after elective PCI
A new JAMA study shows that same-day discharge of selected low-risk Medicare patients who underwent an elective percutaneous coronary intervention (PCI) was not associated with an increased risk of being rehospitalised or having a higher risk of death at two days or at 30 days.
Stenting shows more major adverse events than bypass grafting in complex patients at three years
The rate of major adverse cardiac and cerebrovascular events is significantly higher with percutaneous coronary intervention in patients with left main or three-vessel disease, according to the SYNTAX trial.
Clinical vs. anatomical risk stratification following complex PCI
Ralf Lehmann, Frankfurt, Germany, explains how a combination of clinical and anatomical risk factors may provide the optimal predictive model in patients undergoing multivessel percutaneous coronary intervention.
A fifth of ACS treated patients develop major cardiac events within three years
Between 2004 and 2006, 697 patients with acute coronary syndromes were enrolled at 37 sites in the United States and Europe after undergoing successful percutaneous coronary intervention. Results of the PROSPECT study were published in The New England Journal of Medicine.
Miracor receives CE mark for the PICSO Impulse System
The new device is designed to improve acute coronary syndrome revascularisation following primary percutaneous coronary intervention.
Audio: Interview with Prof Didier Carrié
Prof D. Carrié speaks to Cardiovascular News about progress in percutaneous coronary intervention.
Effient is approved by the FDA
Daiichi Sankyo and Lilly' Effient reduces thrombotic cardiovascular events in patients with acute coronary syndromes managed with percutaneous coronary intervention.
FFR-guided stenting improves outcomes with fewer devices
The FAME trial showed that routine measurements of fractional flow reserve during percutaneous coronary intervention compared to angiographic approach reduces rate of composite endpoint of death.
ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI
Assessing myocardial viability does not aid the selection of patients who will benefit—or not—fr...
Cardiovascular News’ top 10 stories of February 2023
February’s trending topics included a look at the past, present and future of transcatheter aortic v...
ACC 2023: Intravascular imaging bests angiography guidance in trial of PCI in complex lesions
Use of intravascular imaging guidance for percutaneous coronary intervention (PCI) in patients with ...
Important to utilise DCBs with strongest possible data behind them
NOTE: This video is ONLY available to watch in selected countries and geographies
Tuomas Ri...
COPS trial shows feasibility of using a cutting balloon at high pressure to modify calcium prior to PCI
Attendees of the 2023 Joint Interventional Meeting (JIM, 9–11 February, Milan, Italy) heard results ...
PCI probability seen to increase at low-volume hospitals for all populations, but has not occurred “evenly” across sociodemographic groups
A retrospective cohort study has found the likelihood of receiving percutaneous coronary interve...
Cardiovascular News’ top 10 most popular stories of January 2023
In the opening month of 2023, Cardiovascular News’ most read stories include sex disparities in clin...
Home-based therapy can help to reduce anxiety and depression in cardiovascular patients
A randomised study led by Greater Manchester Mental Health NHS Foundation Trust (GMMH) and the U...
ADVERTORIAL: A step forward in scoring balloon catheter design
This advertorial is sponsored by iVascular
A new coronary scoring balloon dilatation catheter...
Automated alert tool “associated with a small decrease in contrast use” during PCI
Performance improvement company Biome Analytics has announced the publication of a study in Circulat...
PCI can be performed as safely without on-site access to surgery, says SCAI
Percutaneous coronary intervention (PCI) without on-site surgical support is as safe as PCI at centr...
Nieves Gonzalo
Interventional cardiology is a rapidly evolving field, offering the opportunity to learn procedures ...
Trial of super saturated oxygen therapy after PCI begins enrolment
Zoll has announced that the first patient has been enrolled in the REAL SSO2 post-market observation...
Effects of short DAPT “consistent regardless of high bleeding risk and complex PCI”
Research evaluating the effects of high bleeding risk (HBR) and complex percutaneous coronary interv...
Depression increases likelihood of non-adherence to medical therapy post-PCI
Patients with depression were 10–20% less likely to adhere to guideline-directed medical therapy aft...
Cardiovascular News’ top stories of 2022
Which stories, features and interviews captured the attention of the cardiovascular community across...
SCAI announces recipients of early career grant scheme
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the four recipie...
Enrolment begins in Impella ECP pivotal trial after US FDA green light
The first two patients have been enrolled in the Impella ECP pivotal trial, after the US Food an...
Pilot study of wire pacing sleeve yields positive results in TAVI and PCI procedures
A first-in-human trial using a purpose-built device to provide direct wire pacing without the need f...
Improved follow-up care needed for Black patients post-PCI to prevent hospital readmission and death
In a recent study which revealed higher readmission and mortality rates among Black patients fol...
Ninety-day readmission and mortality found to be higher among Black patients following PCI
A retrospective analysis of data collected from the Blue Cross Blue Shield of Michigan Cardiovascula...
Timothy D Henry
A pioneer of one of the first regional ST-segment elevation myocardial infarction (STEMI) systems in...
Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND
Extended follow-up of the ISCHEMIA-EXTEND trial has shown no difference in rates of all-cause mo...
BRIGHT-4 trial: Bivalirudin cuts 30-day mortality for STEMI patients undergoing PCI compared to heparin
Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with ST-s...
Siemens Healthineers to demonstrate remote capabilities of Corindus CorPath GRX robotic system using Mentice VIST simulator
Mentice has announced that Siemens Healthineers China is showcasing the remote capabilities of the C...
Use of clinical support platform “reduces risk of kidney injury” from PCI
Patients at high risk for acute kidney injury (AKI), the most common complication of percutaneous co...
MedAlliance to be acquired by Cordis
MedAlliance is to be acquired by Cordis, it was announced today, after the two companies reached agr...
Swedish registry data point to survival benefit for younger patients undergoing CABG
An analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) has s...
Analysis shows survival benefit in high-risk PCI supported by Impella
An analysis of more than 2,000 patients from a large US real-world database finds that patients ...
Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award
The developers of a cannula for minimally-invasive central aortic perfusion—MIC-Cannula—received...
EACTS 2022: Global studies will fill gap for “high-quality evidence” on invasive treatment of ischaemic cardiomyopathy
A global research initiative will compare coronary artery bypass graft surgery (CABG) and percut...
Long-term P2Y12 monotherapy after PCI “may be a promising strategy”
Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor monotherapy was asso...
Enrolment completed in trial comparing PCI in diabetic patients
ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing safety and efficacy of...
Puzzle Medical wins 2022 TCT Shark Tank innovation competition
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation competition at the 2...
Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients
Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To...
FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI
Medtronic has received Food and Drug Administration (FDA) approval for the treatment of non-left mai...
TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures
Results from a multicentre randomised trial comparing ultrasound with fluoroscopic guidance vers...
Abiomed given green light for RECOVER IV randomised trial
Abiomed has announced two approvals from the US Food and Drug Administration (FDA) related to clinic...
First patient joins study of SSO2 therapy post-PCI
Zoll Medical has announced that the first patient has been enrolled in the AMIHOT III post-approval ...
Cardiovascular News’ top 10 most popular stories of August 2022
The most read stories from across Cardiovascular News in August 2022 include highlights from the Eur...
ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI
Fifteen-month results from the MASTER DAPT trial have shown that the preserved ischaemic benefit...
ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI
Selection of non-infarct related artery (IRA) lesions for intervention using fractional flow res...
ESC 2022: POST-PCI trial finds no benefit to routine functional testing in high-risk PCI patients
Among high-risk patients undergoing percutaneous coronary intervention (PCI), a follow-up strate...
ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ho...
Miracor’s PiCSO technology approved by FDA for investigational device exemption study
Miracor Medical has announced the approval of an investigational device exemption (IDE) from the...
Restore EF study “shows heart function, symptom improvements” for high-risk PCI patients supported by Impella
Abiomed has announced the results of the Restore EF study, demonstrating that Impella-supported hig...
Cardiovascular News’ top 10 most popular stories of July 2022
The most read stories from across Cardiovascular News in July 2022 include reflections on the future...
Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine
Cardiac surgeons from North America, Europe and Latin America are among the signatories to a multidi...
Three-year results of RANGO registry presented at EuroPCR
iVascular has announced the release of three-year observational data concerning its Angiolite cobalt...
Cathbot completes enrolment in clinical study of robotic-assisted PCI in China
Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last patient in its clinical...
Analysis shows “positive trend” with thinner strut stents in patients with small vessels
A subgroup analysis of the BIO-RESORT trial has shown a “trend towards better outcomes” with thi...
Cardiovascular News’ top 10 most popular news stories of June 2022
The most read stories from across Cardiovascular News in June 2022 include highlights from TVT 2022 ...
ADVERTORIAL: Advancing radial ergonomics
This advertorial is sponsored by Adept Medical.
Outlining Adept Medical’s process for identifying...
EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies
The use of distal radial artery access for percutaneous coronary intervention (PCI) comes at the...
EuroPCR 2022: Robotic PCI changes the cath lab environment
Robotic-assisted percutaneous coronary intervention (PCI) has the potential to offer a raft of ...
SCAI names Sunil Rao as incoming president
Sunil Rao (Duke University Health System, Durham, USA) has assumed the office of president of th...
EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed
Patients in England with ST-elevation myocardial infarction (STEMI) had an average loss of 1.86 ...
SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”
Analysis of data from a US-wide health system suggests that the volume of percutaneous coronary inte...
EuroPCR 2022 hears new data on robotic PCI
New data on robotic-assisted percutaneous coronary intervention (PCI) have been presented during a l...
EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR 2022 (17–20 May, Pa...
Vijay Kunadian
Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastl...
ADVERTORIAL: Cath lab technologies for medicine in the precision age
This advertorial is sponsored by Siemens Healthineers
In the modern cath lab, having a suite of t...
Cardiovascular News’ top 10 most popular stories of April 2022
The most read stories from across Cardiovascular News in April 2022 include highlights and late-brea...
DCB in PCI: Adjunctive therapy or standard of care?
This educational supplement, sponsored by Medtronic, explores the science underpinning the use of dr...
Japanese and US regulatory approvals granted for BioFreedom stent
Biosensors International Group has announced both the Japanese Pharmaceuticals and Medical Devic...
Cardiovascular News’ top 10 most popular stories of March 2022
The most read stories from across Cardiovascular News in March 2022 include a wealth of late-breakin...
First patient enrolled in BIOMICS study for CTO-PCI
Biosensors International has announced the enrolment of the first patient in the BIOMICS study, a pr...
ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) leads to a fast...
First patient enrolled in PICSO-AMI-V study
Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V study to evaluate Pi...
Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system
Four radial cases using the PH Band System (Medical Ingenuities)—a novel medical device that is ...
Putting “stent regret” behind us
Nick West, chief medical officer and divisional vice president of Global Medical Affairs, Abbott...
CSI’s Propel pVAD system gets first-in-human use
Cardiovascular Systems—CSI—has announced the first in-human experience with Propel, its first-genera...
CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...
Women underrepresented in cardiovascular clinical trial leadership positions
Women remain underrepresented in leading cardiovascular clinical trials, corresponding with unde...
CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years
Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session...
Cardiovascular News’ top 10 most popular stories of January 2022
The most read stories from across Cardiovascular News in January 2022 include controversy surroundin...
SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the release ...
Abbott’s Nick West points to future role of AI in the cath lab
Abbott has released a second round of insights from its Beyond Intervention global research prog...
Susheel Kodali
Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in New York, where he ...
First patient enrolled in TRANSFORM II study of sirolimus-coated balloon
The first patient has been enrolled in the TRANSFORM II randomised controlled trial assessing th...
“Considerable” reduction in PCI-related radiation reported in last decade
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “considerably” during ...
Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines
Terumo Medical Corporation has welcomed the publication of updated guidelines from the American Coll...
Robocath completes European study of robot-assisted PCI
Robocath has announced the conclusion of its R-Evolution clinical study in Europe, which was aimed a...
Cardiovascular News’ top 10 most popular stories of December 2021
The most read stories from December 2021 include analysis of the CHEETAH study and the role of mecha...
Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI
Vesalio recently announced the start of enrolment in its NATURE study using enVast, the company’s fi...
“Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI
Results of the CHEETAH clinical study highlight the potential role of mechanical aspiration thro...
Understanding the risk of acute kidney injury in the cath lab
Huge strides have been made in preventing contrast-associated acute kidney injury among patients...
Cardiovascular News’ top 10 most popular stories of November 2021
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 N...
First patients enrolled in FAST III study of vFFR-guided PCI
The first patients have been enrolled in the FAST III trial at the Erasmus University Medical Center...
Findings of meta-analysis “move the conversation forward” on left main revascularisation
A meta-analysis comparing percutaneous coronary intervention (PCI) using a drug-eluting stent (D...
AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI
An updated risk score to predict possible contrast-associated acute kidney injury (CA-AKI) among...
ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab
This advertorial is sponsored by iVascular
Treatment of a chronic total occlusion (CTO)—a complet...
“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021
Early data presented at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021; ...
TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens
Patients receiving antiplatelet therapy following percutaneous coronary intervention (PCI) devel...
TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella
The final results of the PROTECT III and Restore EF prospective studies demonstrate improved out...
TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart
Penumbra has announced that the CHEETAH clinical study of its Indigo system CAT RX catheter succ...
TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial
Lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed phys...
EACTS speakers question evidence underpinning guidelines for left main revascularisation
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 Octobe...
Longest available real-world follow-up data for Tendyne valve support use of device in select patients
The longest available real-world follow-up data of transcatheter mitral valve implantation (...
Philips’ Bert van Meurs discusses the future of imaging in the cath lab
Bert van Meurs is the chief business leader for Image Guided Therapy within Royal Philips, the multi...
Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent
Biotronik has announced that it has received US Food and Drug Administration (FDA) approval of i...
“No red flags” for ticagrelor monotherapy according to stent type
George Dangas (New York, USA) discusses the results of the TWILIGHT-Stent trial, presented at the...
Ultrasound guidance “should be routine” for transfemoral TAVI access
Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI) is associated with...
Christoph Naber
Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career in interventional car...
ABILITY Diabetes Global enrols thousandth patient
Concept Medical has announced the enrolment of the thousandth patient in ABILITY Diabetes Global (Ra...
Cardiovascular News’ top 10 most popular stories of August 2021
August’s top 10 features a stark warning over representation of women in clinical trials relating to...
ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS
Findings of the STOPDAPT-2 ACS trial presented during a hot line session at the European Society...
ESC 2021: One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI
Marco Valgimigli (Lugano, Switzerland) talks to Cardiovascular News about the latest findin...
Ten-year outcomes of Yukon DES in diabetic patients published in JAHA
Translumina has announced the publication of 10-year clinical outcome data for its Yukon drug-elutin...
App launched to cut time to treatment for STEMI patients
Physicians at Mount Sinai Health System (New York, USA) have developed a mobile application to exped...
Cardiovascular News’ top 10 most popular stories of July 2021
Our top 10 stories of July 2021, including: A milestone for coronary balloon angioplasty; highlights...
Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19
The largest analysis of its kind to look at the impact of COVID-19 on adult cardiac surgery volu...
PCI procedures drop by 10% in USA since 2010, research suggests
The USA saw a 10% decline in percutaneous coronary intervention (PCI) procedures between 2010 an...
Medtronic launches Prevail DCB in Europe
Medtronic has announced the launch of the Prevail drug coated balloon (DCB) catheter in Europe follo...
TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year
Patients with bicuspid aortic stenosis may benefit as much from transcatheter aortic valve impla...
Common cath lab practices under the microscope in AHA review
The American Heart Association (AHA) has published a scientific statement challenging “tradition...
Carta Healthcare’s AI software certified for use in CathPCI Registry
Carta Healthcare has announced that it has been certified as a National Cardiovascular Data Registry...
Royal Philips announces start of DEFINE GPS study
Royal Philips has announced the official start of the DEFINE GPS study, with the first patient b...
Registry DAPT data “could support clinical trials”
Data captured in the National Cardiovascular Data Registry (NCDR) is similar in quality, depth a...
Cindy Grines
Cindy Grines is an interventional cardiologist and chief scientific officer of Northside Hospital Ca...
Delaying CABG after AMI may not improve outcomes
A study looking at the timing of coronary artery bypass grafting (CABG) after the occurrence of acut...
Targeted healing: A new stent concept that could contribute to shortened DAPT
This advertorial is sponsored by Sinomed
As newer-generation drug-eluting stent (DES) technol...
Physician gender does not impact outcomes in PCI patients
There does not appear to be a relationship between operator and patient gender and outcome in patien...
Intravascular lithotripsy: Not an eccentric option for eccentric calcium
This advertorial is sponsored by Shockwave Medical.
Severe coronary artery calcification presents...
EuroPCR 2021: Image-guided PCI study demonstrates non-inferiority of ultra-thin stent
Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting (BP-SES; Orsiro, Bi...
RE-ACCESS study has implications for TAVI valve selection
This advertorial is sponsored by Boston Scientific
In recent years, transcatheter aortic valv...
EuroPCR 2021: Study details dual mechanism of Diamondback orbital atherectomy system
Results of an observational study using optical coherence tomography (OCT) to assess the efficac...
EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold
One-year results of the FUTURE-II study—a randomised trial comparing a thin-strut bioresorbable ...
ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI
Clopidogrel monotherapy produced better outcomes than aspirin for the long-term maintenance of p...
FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool
This advertorial is sponsored by PIE Medical
Findings of the multicentre FAST II clinical tri...
EuroPCR 2021: Philips shares cardiac imaging and software developments
Royal Philips has announced the European availability of new innovations in its portfolio of solutio...
ZOLL Medical receives FDA IDE approval for ISO Shock study
ZOLL Medical Corporation has announced that the US Food and Drug Administration (FDA) has approv...
ACC.21: FLOWER-MI finds no benefit to FFR-guided PCI in STEMI patients with multi-vessel disease
ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel disease undergoing percuta...
ACC.21: DAPT de-escalation may benefit AMI patients
Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) after 30 days was safe...
COBRA PzF stent demonstrates long-term safety at five years post-PCI
CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achieved exceptional lon...
ACC.21: Digital app should replace stent cards as a patient PCI record
Fewer than half (48%) of patients undergoing percutaneous coronary intervention (PCI) still had ...
Cardiovascular News’ top 10 most popular stories of April 2021
Our top 10 stories of April 2021, including: highlights from the Society for Cardiovascular Angiogra...
ACC.21: App speeds up time to PCI for STEMI patients
ST-elevation myocardial infarction (STEMI) patients received percutaneous coronary intervention (PCI...
SCAI 2021: ISCHEMIA trial population not reflected in real-world patients
Patients studied in the ISCHEMIA trial, the largest trial to date to compare revascularisation w...
SCAI 2021: Robotic PCI achieves high clinical and technical success “in a wide spectrum of lesions”
Robotic-assisted percutaneous coronary intervention (PCI) using the second-generation CorPath GR...
SCAI 2021: Prolonged DAPT “should remain the standard of care” in ACS patients
Analysis of the prospective Fuwai PCI Registry using selection criteria from the TWILIGHT trial, has...
SCAI 2021: Research lays bare the impact of the COVID-19 pandemic on STEMI care
Two research papers presented at the Society for Cardiovascular Angiography and Interventions vi...
CytoSorbents granted US FDA approval for STAR-T trial
CytoSorbents has announced that the US Food and Drug Administration (FDA) has granted conditional ap...
Societies publish initial findings of NACMI registry of STEMI patients with COVID-19
Initial findings from the North American Cardiovascular COVID-19 Myocardial Infarction (NACMI) R...
First patient enrolled in PROTECT IV randomised controlled trial of Impella
Abiomed has announced that the first patient has been enrolled in PROTECT IV, a large, prospecti...
Understanding trends in TAVI and surgical aortic valve replacement
With recent data pointing to a shift towards more transcatheter aortic valve implantation (TAVI) pro...
Older STEMI patients found to be more reluctant to undergo PCI in Chinese study
Patients aged over 65 years were more likely than their younger counterparts to turn down percutaneo...
How the LightLab initiative is examining the value of OCT in the cath lab
Matheen Khuddus (director of Cardiovascular Research, The Cardiac & Vascular Institute, Gainesvi...
Stephan Achenbach
Stephan Achenbach is professor of medicine at the University of Erlangen, Erlangen, Germany and pres...
CRT 2021: Three-year COMPARE ABSORB results show similar TLF rate between Absorb scaffold and Xience stent
Three-year results from the COMPARE-ABSORB trial, presented during a late-breaking trial session...
CardioRisk: Addressing atherosclerotic risk factors among Egypt’s ACS patients
Ahmed Bendary (Benha University, Benha, Egypt) details the CardioRisk project, an initiative to ...
CRT 2021: BIOSTEMI shows superiority of Orsiro stent to Xience for target lesion failure at two years
Two-year follow-up data the BIOSTEMI trial, presented during a late-breaking trial session at th...
ACC.21 late-breaking clinical trial programme announced
The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials...
Cardiovascular News’ top 10 most popular stories of February 2021
Our top 10 stories of February 2021, including: the relationship between TAVI volumes and outcomes; ...
Approval allows use of single access Impella procedure across Europe
Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single acces...
Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial
Favourable rates of ischaemic outcomes were observed among selected high bleeding risk patients ...
CRT 2021: Analysis compares cangrelor favourably to glycoprotein IIB
An analysis of antiplatelet therapies used during percutaneous coronary intervention (PCI) has c...
CRT 2021: Recre8 sub-analysis points to higher rate of clinically relevant bleeding in HBR patients during DAPT
A sub-analysis of the Recre8 trial, assessing patients at high bleeding risk (HBR) undergoing pe...
OpSens gains CE mark for OptoWire III
OpSens has received CE mark approval for the OptoWire III, the latest generation of its flagship pro...
What role will remote robotic procedures play in the future of PCI?
With the COVID-19 pandemic creating new barriers to the accessibility of healthcare, the success...
Teleflex completes enrolment in CTO-PCI IDE study
Teleflex has announced the completion of patient enrolment in a clinical study evaluating the perfor...
Ticagrelor monotherapy associated with a lower bleeding risk than standard DAPT after PCI
Dropping aspirin shortly after percutaneous coronary intervention (PCI) is associated with lower...
New recommendations issued on antithrombotic treatment of AF patients undergoing PCI
Updated recommendations on the optimal antithrombotic treatment of patients with atrial fibrillation...
Rate of target vessel failure “significantly lower” after IVUS-guided PCI
Drug-eluting stent implantation guided by intravascular ultrasound (IVUS) is associated with signifi...
Comparative study reports favourable outcomes for VasoStat haemostasis device
Forge Medical has announced the publication of results of an investigator-initiated randomised trial...
Analysis of ADAPT-DES registry grades risk of stent thrombosis after PCI
An analysis of data from the ADAPT-DES registry, published in JACC: Cardiovascular Interventions, in...
Diamondback 360 atherectomy system gains CE mark
Cardiovascular Systems has received the CE mark for its Diamondback 360 coronary orbital atherec...
Elixir Medical announces treatment of first patient in BIOADAPTOR trial
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that...
Complete revascularisation achieved in one quarter of patients with acute MI complicated by cardiogenic shock
Complete revascularisation is rarely achieved in patients with multivessel coronary artery disea...
First remote robotic-assisted PCI completed in Europe using R-One platform
Robocath has announced the successful completion of the first remote robotic-assisted percutaneo...
Analysis of STEMI patients finds little difference between prasugrel and ticagrelor after PCI
A subgroup analysis of the ISAR REACT-5—Intracoronary Stenting and Antithrombotic Regimen: Rapid Ear...
Abiomed completes first stage in early feasibility study of ECP heart pump
Abiomed has announced that its Impella ECP heart pump has completed the first stage in its US Food a...
Abbott launches virtual reality training programme for cardiologists using OCT imaging technology
Abbott has announced the global release of its first virtual reality-based training programme design...
PCR Valves: ACTIVATION trial finds no difference in one-year mortality or rehospitalisation from PCI prior to TAVI
The first randomised trial comparing a course of pre-procedure percutaneous coronary interventio...
AHA 2020: Ticagrelor not superior to clopidogrel in reducing severe complications after PCI
The use of ticagrelor was not superior to clopidogrel in the reduction of the rate of severe com...
Michael Reardon
A pioneer in the field of transcatheter aortic valve implantation (TAVI), Michael Reardon (professor...
Results from Onyx One Clear study published
Results of the Onyx One Clear study, evaluating the safety and effectiveness of one-month dual a...
England’s first COVID-19 lockdown led to a significant drop in PCI procedures
A significant decline in percutaneous coronary intervention (PCI) procedures was seen in England...
Ticagrelor may not be superior to clopidogrel in ACS patients undergoing PCI
The use of ticagrelor in patients with acute coronary syndrome (ACS) undergoing percutaneous coronar...
The benefits of optical coherence tomography in the cath lab
Kevin Croce, director, Chronic Total Occlusion and Complex Percutaneous Coronary Intervention Pr...
First patients treated with the Impella ECP heart pump
Abiomed has announced the treatment of the first two patients using the Impella ECP expandable percu...
Panel explores the unanswered questions around short duration DAPT
Mounting evidence over the safety and efficacy of shorter-term dual antiplatelet therapy (DAPT) ...
Meta-analysis supports use of all-cause mortality in PCI versus CABG trials
A meta-analysis of 23 randomised clinical trials comparing percutaneous coronary intervention (P...
Biosensors gains CE mark approval for BioFreedom Ultra stent system
Biosensors has announced the award of a CE mark for BioFreedom Ultra drug-coated coronary stent syst...
TCT Connect 2020: Durable polymer DES non-inferior to biodegradable polymer stents in ACS patients
Results of the HOST-REDUCE-POLYTECH-ACS, presented at TCT Connect 2020 (14–18 October, virtual) ...
TCT Connect 2020: Disrupt CAD III meets safety and effectiveness endpoints
Shockwave Medical has announced that the coronary Investigational Device Exemption (IDE) study—Disru...
TCT Connect 2020: Philips announces one-year results of DEFINE PCI
Royal Philips has announced one-year results of the DEFINE PCI study, presented at TCT Connect 2020 ...
TCT Connect 2020: XIENCE trials demonstrate non-inferiority of shorter-term DAPT regimens
A shorter course of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (P...
TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF
An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (14–18 October, virtu...
TCT Connect 2020: Results demonstrate safety and procedural success of orbital atherectomy system
Cardiovascular Systems has announced the presentation of results from a large retrospective obse...
TCT Connect 2020: Primary PCI is preferable in COVID-19 positive patients with ST-Elevation
Initial findings from the North American COVID-19 ST-Segment Elevation Myocardial Infarction (NA...
TCT Connect 2020: PCI of non-flow-limiting vulnerable plaques is safe and enlarges follow-up lumen area
A pilot randomised trial of percutaneous coronary intervention (PCI) of non-flow-limiting vulnerable...
Robotics and advanced imaging provide protection and precision in PCI
This article, part of an educational supplement sponsored by Siemens Healthineers, details the use...
EXCEL analysis supports protocol definition of procedural myocardial infarction
An analysis of the rates and clinical implications of alternative definitions of procedural myocardi...
Medtronic’s Resolute Onyx approved for one-month DAPT labelling by US FDA
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for ...
Review looks at TAVI device selection and concludes head-to-head studies needed
Transcatheter aortic valve implantation (TAVI) device selection should be guided by patient, ana...
The challenges of the modern cath lab
Over the last decade, the cath lab has transformed. Interventional cardiologists are now not only tr...
IVUS linked to favourable PCI outcomes, but uptake is low
A study of US Medicare patients undergoing percutaneous coronary intervention (PCI) has found th...
J Dawn Abbott
J Dawn Abbott is the director of interventional cardiology and an associate professor of medicine in...
A variety of tools are now available for physiological assessment
Multiple studies have shown that fractional flow reserve (FFR) is a valuable modality for assessing ...
TIDES-ACS confirms performance of Hexacath’s titanium-nitride-oxide coated stent
Results of the TIDES-ACS randomised controlled trial, confirming the superior safety and sustain...
Japan and the USA see an increase in PCI procedures
Japan and the USA have seen an increase in percutaneous coronary intervention (PCI) procedures, whic...
First patient enrolled in TRANSFORM-1 study of MagicTouch DCB
Concept Medical has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt o...
ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk patients
An invasive approach involving either percutaneous coronary intervention (PCI) or coronary arter...
Miracor secures financing to support PiCSO clinical study
Miracor Medical has announced the closing of a €24 million series-E round of financing. The roun...
ESC 2020 Congress: AF associated with long-term mortality in primary PCI patients regardless of LV function
Atrial fibrillation (AF) is associated with long-term mortality in patients undergoing primary p...
Chinese study suggests STEMI patients had increased mortality risk during COVID-19 pandemic
The risk of in-hospital death and in-hospital heart failure increased for ST-elevation myocardial in...
Biosensors announces enrolment of first patient in REFORM pivotal trial
Biosensors announced today the enrolment of the first patient in REFORM—a prospective, randomised, n...
